Cited by 43Genomics and Rare DiseasesGenetics and Neurodevelopmental DisordersGenomic variations and chromosomal abnormalities

Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability

Open access
Hamilton, Mark J, Caswell, Richard C, Canham, Natalie, Cole, Trevor, Firth, Helen V, Foulds, Nicola, Heimdal, Ketil, Hobson, Emma +16 more·2018·Journal of Medical Genetics

Abstract

Introduction: Recent evidence has emerged linking mutations in CDK13 to syndromic congenital heart disease. We present here genetic and phenotypic data pertaining to 16 individuals with CDK13 mutations. Methods: Patients were investigated by exome sequencing, having presented with developmental delay and additional features suggestive of a syndromic cause. Results: Our cohort comprised 16 individuals aged 4–16 years. All had developmental delay, including six with autism spectrum disorder. Common findings included feeding difficulties (15/16), structural cardiac anomalies (9/16), seizures (4/16) and abnormalities of the corpus callosum (4/11 patients who had undergone MRI). All had craniofacial dysmorphism, with common features including short, upslanting palpebral fissures, hypertelorism or telecanthus, medial epicanthic folds, low-set, posteriorly rotated ears and a small mouth with thin upper lip vermilion. Fifteen patients had predicted missense mutations, including five identical p.(Asn842Ser) substitutions and two p.(Gly717Arg) substitutions. One patient had a canonical splice acceptor site variant (c.2898–1G>A). All mutations were located within the protein kinase domain of CDK13. The affected amino acids are highly conserved, and in silico analyses including comparative protein modelling predict that they will interfere with protein function. The location of the missense mutations in a key catalytic domain suggests that they are likely to cause loss of catalytic activity but retention of cyclin K binding, resulting in a dominant negative mode of action. Although the splice-site mutation was predicted to produce a stable internally deleted protein, this was not supported by expression studies in lymphoblastoid cells. A loss of function contribution to the underlying pathological mechanism therefore cannot be excluded, and the clinical significance of this variant remains uncertain. Conclusions: These patients demonstrate that heterozygous, likely dominant negative mutations affecting the protein kinase domain of the CDK13 gene result in a recognisable, syndromic form of intellectual disability, with or without congenital heart disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jmedgenet-2017-104620

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hamilton, M. J., Caswell, R. C., Canham, N., Cole, T., Firth, H. V., Foulds, N., Heimdal, K., Hobson, E., Houge, G., Joss, S., Kumar, D., Lampe, A. K., Maystadt, I., McKay, V., Metcalfe, K., Newbury-Ecob, R., Park, S.-M., Robert, L., Rustad, C. F., Wakeling, E., Wilkie, A. O. M., Study, T. D. D. D., Twigg, S. R. F., & Suri, M.
Affiliations
  • Nottingham University Hospitals NHS Trust (GB)
  • University of Exeter (GB)
  • London North West Healthcare NHS Trust (GB)
  • Birmingham Women's Hospital (GB)
  • Wellcome Sanger Institute (GB)
  • University Hospital Southampton NHS Foundation Trust (GB)
  • Oslo University Hospital (NO)
  • Leeds Teaching Hospitals NHS Trust (GB)
  • Haukeland University Hospital (NO)
  • Queen Elizabeth University Hospital (GB)
  • University Hospital of Wales (GB)
  • Western General Hospital (GB)
  • Institute of Pathology and Genetics (BE)
  • Liverpool Womens NHS Foundation Trust (GB)
  • Manchester Academic Health Science Centre (GB)
  • University Hospitals Bristol NHS Foundation Trust (GB)
  • East Anglian Regional Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK
  • Guy's Hospital (GB)
  • University of Oxford (GB)
  • Wellcome Trust Sanger Institute, Hinxton, UK
Corresponding author
Suri, Mohnish
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2017-10-11
Volume
55
Issue
1
Pages
28-38
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2763856094
Cited by
43
References
20
Citations by year
2026: 1 · 2025: 2 · 2024: 7 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 5
FWCI
3.26
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Medical Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion, cc-by)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Health Innovation Challenge Fund
  • Wellcome Trust
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
CDK13, kinase domain, developmental delay, intellectual disability, autism spectrum disorder, syndromic intellectual disability, missense mutations, splice site mutation, craniofacial dysmorphism, congenital heart disease, feeding difficulties, seizures, corpus callosum abnormalities, loss of function, dominant-negative mechanism
MeSH terms
Protein Domains, Adolescent, Child, Developmental Disabilities, Female, Heterozygote, Humans, Male, Intellectual Disability, Models, Molecular, Mutation, Syndrome, Thermodynamics, CDC2 Protein Kinase, Conserved Sequence, Mutation, Missense

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review